CELLECTIS

Summary

Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 202 M

Avg. Deal Size£ 202 M

Market Context

Senior Management